AnxietyNCT07868783
Transcendental Meditation Intervention to Reduce Burnout and Enhance Resilience Among NewYork-Presbyterian Hospital and Weill Cornell Medicine Employees and Residents
A study testing Transcendental Meditation in people with Anxiety and Depression - Major Depressive Disorder, run by Weill Medical College of Cornell University at 1 site in United States.
Trial summary
The goal of this study is to learn if a meditation intervention called Transcendental Meditation or TM can be used in a small department at Weill Cornell Medicine to help reduce employees' levels of burnout, anxiety, insomnia, and depression as well as to determine the feasibility and acceptability of the meditation… Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Anxiety, Depression - Major Depressive Disorder, Burnout
- What is being tested?
- Transcendental Meditation
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 15 participants
- Where
- 1 siteUnited States
- Study dates
- 15 Nov 2026to 27 Nov 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Be 18 years of age or older
- Be a full-time employee at Weill Cornell Medicine or NewYork-Presbyterian Hospital.
- Agree to complete the entire TM training program of eight sessions and practice the TM technique twice daily for approximately 20 minutes.
- Agree to complete a battery of self-report baseline and post-test surveys online (1-month and 3-months post baseline).
- If being treated with psychoactive medications, have maintained a stable regimen for at least two months prior to enrollment.
- Can commit to remaining in the New York area for 3 ½ consecutive months (with the exception of brief trips, e.g., weekend trips) for the duration of the study period (baseline measures through 3-month post-testing).
Who cannot join
- Are younger than 18 years of age.
- Are already instructed in the Transcendental Meditation technique.
- Are not a full-time employee at Weill Cornell Medical College or NewYork-Presbyterian Hospital.
- Are unwilling to complete the entire TM training program of eight sessions and practice the TM technique twice daily for approximately 20 minutes.
- Are unwilling to complete a battery of self-report surveys online at baseline, at one month, and at three months post-baseline.
- Have an unstable regimen of psychoactive medications in the past two months or psychiatric hospitalization in the last six months, per self-report.
- Are unable to commit to remaining in the New York area for 3 ½ consecutive months (with the exception of brief trips, e.g., weekend trips) for the duration of the study period (baseline measures through 3-month post-testing).
- This study will not include Adults unable to consent, Individuals who are not yet adults (infants, children, teenagers), and prisoners. The study may include pregnant women.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
Weill Cornell Medicine, Starr Facility
New York, New York, 10065
Valentina Marulanda-Corzo, MD, (646) 642 1917, vam4009@med.cornell.edu
Joseph Osborne, MD, PhD
About this study
Official title: A Pilot Intervention to Reduce Burnout and Enhance Resilience Through Transcendental Meditation Among NewYork-Presbyterian Hospital and Weill Cornell Medicine Employees and Residents
The goal of this study is to learn if a meditation intervention called Transcendental Meditation or TM can be used in a small department at Weill Cornell Medicine to help reduce employees' levels of burnout, anxiety, insomnia, and depression as well as to determine the feasibility and acceptability of the meditation practice by Weill Cornell employees. The main question the study aims to answer is whether:
- Levels of burnout, anxiety, insomnia, and depression will be decreased, and overall mental well-being will improve over a 3.5-month period before and after TM intervention.
Participants will attend 9 sessions total (8 group sessions and 1 individual session) with a certified TM instructor from The David Lynch Foundation Institute for Mental Health and Resilience where they will gain experience in proper TM techniques. Also, participants will conduct 2 of their own TM sessions at home daily during the course of this study.
- Conditions
- Anxiety, Depression - Major Depressive Disorder, Burnout, Insomnia, Resilience, Feasibility
- Being tested
- Transcendental Meditation
- Keywords
- Transcendental Meditation, TM, burnout
- Medical subject headings
- Anxiety Disorders, Burnout, Psychological, Sleep Initiation and Maintenance Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Transcendental MeditationBehavioural
Also called TM
Participants will undergo a TM training program of nine sessions and practice the TM technique twice daily for approximately 20 minutes.The TM training program will include a total of 9 sessions conducted by experienced certified TM instructors: an introductory session (Session 0, described above), core instruction consisting of 4 sessions taught on 4 consecutive days (Sessions 1-4, 60-75 minutes each), followed by 4 follow-up sessions offered at intervals over the following 3 months (Sessions 5-8, 45 minutes each). All 9 sessions will be completed within 3.5 months from the time of the first session.
| Study group | Role | What they receive |
|---|---|---|
| Transcendental Meditation | Experimental | Participants will undergo a TM training program of nine sessions and practice the TM technique twice daily for approximately 20 minutes Receives: Behavioral: Transcendental Meditation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Adherence to home practice of TM (1 month from baseline)
Adherence to home TM practice will be assessed at 1 month post TM instruction, using a self-report form. Adherence to home TM practice will be the number of participants who responded that they did at least one home TM practice session per day on average out of all study participants. The self report survey asks participants over the past week and month how often they have done TM at home with three choices: 1) Twice a day, 2) Once a Day, and 3) Rarely or not at all. "Adherence" to home TM practice will be defined as at least one home TM practice session per day on average on this survey.
Measured: 1 month
Adherence to home practice of TM (3 months from baseline)
Adherence to home TM practice will be assessed at 3 month post TM instruction, using a self-report form. Adherence to home TM practice will be the number of participants who responded that they did at least one home TM practice session per day on average out of all study participants. The self report survey asks participants over the past week and month how often they have done TM at home with three choices: 1) Twice a day, 2) Once a Day, and 3) Rarely or not at all. "Adherence" to home TM practice will be defined as at least one home TM practice session per day on average on this survey.
Measured: 3 month
Percentage of participants who attend 6 of the 8 training sessions over the course of the 3-month study
Attendance at TM training sessions (feasibility) will be quantified as a binary outcome (either yes or no) based on whether at least 80% of the participants attend 6 of the 8 training sessions over the course of the 3 month study.
Measured: 3 months
Change in Level of Anxiety from Baseline to 1 month
Anxiety symptoms will be evaluated between baseline and 1 month with the Generalized Anxiety Disorder-7 (GAD-7) which is a brief 7-item anxiety questionnaire. The survey has 7 question prompts evaluating anxiety symptoms over the past 2 weeks and ranges from the lowest score of 0 to highest total score of 21. The highest score indicates severe anxiety while the lowest score indicates minimal anxiety.
Measured: baseline, 1 month
Change in Level of Anxiety from Baseline to 3 months
Anxiety symptoms will be evaluated between baseline and 3 months with the Generalized Anxiety Disorder-7 (GAD-7) which is a brief 7-item anxiety questionnaire . The survey has 7 question prompts evaluating anxiety symptoms over the past 2 weeks and ranges from the lowest score of 0 to highest total score of 21. The highest score indicates severe anxiety while the lowest score indicates minimal anxiety.
Measured: baseline, 3 months
Change in Depression Score from Baseline to 1 Month
The depression score will be measured by the NIH Promis Emotional Distress-Depression Short Form 6a. The survey has 6 questions prompts evaluating depression levels over the past week. The survey ranges from a lowest score of 0 indicating minimal to no depression and a highest score of 30 indicating severe depression. These surveys will evaluate change in depression from baseline to 1 month.
Measured: baseline, 1 month
Change in Depression Score from Baseline to 3 Months
The depression score will be measured by the NIH Promis Emotional Distress-Depression Short Form 6a. The survey has 6 questions prompts evaluating depression levels over the past week. The survey ranges from a lowest score of 0 indicating minimal to no depression and a highest score of 30 indicating severe depression. These surveys will evaluate change in depression from baseline to 3 months.
Measured: Baseline, 3 months
Change in Burnout Score from Baseline to 1 Month
Changes in feelings of burnout will be measured by the Maslach Burnout Inventory for Medical Personnel and will be assessed between baseline and 1 month. This survey has 22 question prompts related to how the employee feels from work related stress over the course of year. Respondents rate items on a frequency scale from 0 (Never) to 6 (Every day). The scores for the following three categories are added up independently:
- Emotional Exhaustion (EE): 9 items summed to a range of 0 to 54. Higher scores mean greater emotional depletion while lower score indicate less emotional exhaustion
- Depersonalization / Cynicism (DP): 5 items summed to a range of 0 to 30. Higher scores mean greater detachment and cynicism while lower scores indicate less detachment or cynicism
- Personal Accomplishment (PA): 8 items summed to a range of 0 to 48. Lower scores indicate reduced professional efficacy and a higher risk of burnout while higher scores indicate less burnout risk and more accomplishment.
Measured: baseline, 1 month
Change in Burnout Score from Baseline to 3 Months
Changes in feelings of burnout will be measured by the Maslach Burnout Inventory for Medical Personnel and will be assessed between baseline and 1 month. This survey has 22 question prompts related to how the employee feels from work related stress over the course of year. Respondents rate items on a frequency scale from 0 (Never) to 6 (Every day). The scores for the following three categories are added up independently:
- Emotional Exhaustion (EE): 9 items summed to a range of 0 to 54. Higher scores mean greater emotional depletion while lower score indicate less emotional exhaustion
- Depersonalization / Cynicism (DP): 5 items summed to a range of 0 to 30. Higher scores mean greater detachment and cynicism while lower scores indicate less detachment or cynicism
- Personal Accomplishment (PA): 8 items summed to a range of 0 to 48. Lower scores indicate reduced professional efficacy and a higher risk of burnout while higher scores indicate less burnout risk and greater accomplishment
Measured: Baseline, 3 months
Change in Sleep Disturbance from Baseline to 1 Month
Change in sleep disturbance between 1 month and baseline will be evaluated with the Insomnia Severity Index which has 7 question prompts. The survey ranges from a low score of 0 indicating no sleep disturbance to a maximum score of 28 indicating severe clinical insomnia.
Measured: baseline, 1 month
Change in Sleep Disturbance from Baseline to 3 Month
Change in sleep disturbance between 3 month and baseline will be evaluated with the Insomnia Severity Index which has 7 question prompts. The survey ranges from a low score of 0 indicating no sleep disturbance to a maximum score of 28 indicating severe clinical insomnia.
Measured: Baseline, 3 Months
Secondary outcomes (4)
Change Mental Well-Being from Baseline to 1 month
Change in mental well-being between baseline and 1 month will measured by the Warwick-Edinburgh Mental Well-Being Scale which is a 14 item survey assessing feelings and thoughts regarding well-being over the past 2 weeks. The scores range from a low of 14 indicating very poor well being to a high of 70 indicating very good well being.
Measured: baseline, 1 month
Change in Mental Well Being from Baseline to 3 Months
Change in mental well-being between baseline and 3 months will measured by the Warwick-Edinburgh Mental Well-Being Scale which is a 14 item survey assessing feelings and thoughts regarding well-being over the past 2 weeks. The scores range from a low of 14 indicating very poor well being to a high of 70 indicating very good well being.
Measured: baseline, 3 month
Change in Resilience Score from Baseline to 1 Month
Resilience scores will be measured by the Brief Resilience Scale (BRS) at Baseline and 1 month and the change in scores calclulated. The BRS is a 6 item survey with scores ranging from a low of 6 to a high of 30. 6 indicates very low resilience and 30 superior resilience
Measured: baseline, 1 month
Change in Resilience Score from Baseline to 3 Months
Resilience scores will be measured by the Brief Resilience Scale (BRS) at Baseline and 3 months and the change in scores calclulated. The BRS is a 6 item survey with scores ranging from a low of 6 to a high of 30. 6 indicates very low resilience and 30 superior resilience
Measured: Baseline, 3 Months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Oct 2026
- Study start15 Nov 2026 (estimated)
- Primary completion15 Mar 2027 (estimated)
- Study completion27 Nov 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AnxietyStudies of the same condition, open and under way.
- More trials run by Weill Medical College of Cornell UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 15 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Weill Medical College of Cornell University
- Sponsor type
- University, hospital or other
- Collaborators
- Institute for Mental Health and Resilience of the David Lynch Foundation
- Responsible party
- Sponsor
- Investigators
- Joseph Osborne, MD, PhD, Principal investigator, Weill Cornell Medicine Department of Nuclear Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07868783
- Sponsor's protocol ID
- 26-04030087
- Status last verified
- Oct 2026
- First submitted
- 5 Oct 2026
- Last updated
- 9 Oct 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Pilot Intervention to Reduce Burnout and Enhance Resilience Through Transcendental Meditation Among NewYork-Presbyterian Hospital and Weill Cornell Medicine Employees and Residents
- ClinicalTrials.gov ID
- NCT07868783
- Acronym / sponsor ID
- 26-04030087
- Conditions
- Anxiety, Depression - Major Depressive Disorder, Burnout, Insomnia, Resilience, Feasibility
- Keywords
- Transcendental Meditation, TM, burnout
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 15 participants (estimated)
- Lead sponsor
- Weill Medical College of Cornell UniversityUniversity, hospital or other
- Collaborators
- Institute for Mental Health and Resilience of the David Lynch Foundation
- Study start
- 15 Nov 2026 (estimated)
- Primary completion
- 15 Mar 2027 (estimated)
- Study completion
- 27 Nov 2027 (estimated)
- First posted
- 9 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this study is to learn if a meditation intervention called Transcendental Meditation or TM can be used in a small department at Weill Cornell Medicine to help reduce employees' levels of burnout, anxiety, insomnia, and depression as well as to determine the feasibility and acceptability of the meditation practice by Weill Cornell employees. The main question the study aims to answer is whether:
- Levels of burnout, anxiety, insomnia, and depression will be decreased, and overall mental well-being will improve over a 3.5-month period before and after TM intervention.
Participants will attend 9 sessions total (8 group sessions and 1 individual session) with a certified TM instructor from The David Lynch Foundation Institute for Mental Health and Resilience where they will gain experience in proper TM techniques. Also, participants will conduct 2 of their own TM sessions at home daily during the course of this study.
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Transcendental Meditation | Experimental | Behavioral: Transcendental MeditationParticipants will undergo a TM training program of nine sessions and practice the TM technique twice daily for approximately 20 minutes |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Be 18 years of age or older
- Be a full-time employee at Weill Cornell Medicine or NewYork-Presbyterian Hospital.
- Agree to complete the entire TM training program of eight sessions and practice the TM technique twice daily for approximately 20 minutes.
- Agree to complete a battery of self-report baseline and post-test surveys online (1-month and 3-months post baseline).
- If being treated with psychoactive medications, have maintained a stable regimen for at least two months prior to enrollment.
Key exclusion criteria (8 listed)
- Are younger than 18 years of age.
- Are already instructed in the Transcendental Meditation technique.
- Are not a full-time employee at Weill Cornell Medical College or NewYork-Presbyterian Hospital.
- Are unwilling to complete the entire TM training program of eight sessions and practice the TM technique twice daily for approximately 20 minutes.
- Are unwilling to complete a battery of self-report surveys online at baseline, at one month, and at three months post-baseline.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Transcendental MeditationAlso: TMParticipants will undergo a TM training program of nine sessions and practice the TM technique twice daily for approximately 20 minutes.The TM training program will include a total of 9 sessions conducted by experienced certified TM instructors: an introductory session (Session 0, described above), core instruction consisting of 4 sessions taught on 4 consecutive days (Sessions 1-4, 60-75 minutes each), followed by 4 follow-up sessions offered at intervals over the following 3 months (Sessions 5-8, 45 minutes each). All 9 sessions will be completed within 3.5 months from the time of the first session. | Behavioural | Transcendental Meditation |
Primary outcome
Adherence to home practice of TM (1 month from baseline)
Time frame: 1 month
Adherence to home TM practice will be assessed at 1 month post TM instruction, using a self-report form. Adherence to home TM practice will be the number of participants who responded that they did at least one home TM practice session per day on average out of all study participants. The self report survey asks participants over the past week and month how often they have done TM at home with three choices: 1) Twice a day, 2) Once a Day, and 3) Rarely or not at all. "Adherence" to home TM practice will be defined as at least one home TM practice session per day on average on this survey.
Adherence to home practice of TM (3 months from baseline)
Time frame: 3 month
Adherence to home TM practice will be assessed at 3 month post TM instruction, using a self-report form. Adherence to home TM practice will be the number of participants who responded that they did at least one home TM practice session per day on average out of all study participants. The self report survey asks participants over the past week and month how often they have done TM at home with three choices: 1) Twice a day, 2) Once a Day, and 3) Rarely or not at all. "Adherence" to home TM practice will be defined as at least one home TM practice session per day on average on this survey.
Percentage of participants who attend 6 of the 8 training sessions over the course of the 3-month study
Time frame: 3 months
Attendance at TM training sessions (feasibility) will be quantified as a binary outcome (either yes or no) based on whether at least 80% of the participants attend 6 of the 8 training sessions over the course of the 3 month study.
Change in Level of Anxiety from Baseline to 1 month
Time frame: baseline, 1 month
Anxiety symptoms will be evaluated between baseline and 1 month with the Generalized Anxiety Disorder-7 (GAD-7) which is a brief 7-item anxiety questionnaire. The survey has 7 question prompts evaluating anxiety symptoms over the past 2 weeks and ranges from the lowest score of 0 to highest total score of 21. The highest score indicates severe anxiety while the lowest score indicates minimal anxiety.
Change in Level of Anxiety from Baseline to 3 months
Time frame: baseline, 3 months
Anxiety symptoms will be evaluated between baseline and 3 months with the Generalized Anxiety Disorder-7 (GAD-7) which is a brief 7-item anxiety questionnaire . The survey has 7 question prompts evaluating anxiety symptoms over the past 2 weeks and ranges from the lowest score of 0 to highest total score of 21. The highest score indicates severe anxiety while the lowest score indicates minimal anxiety.
Change in Depression Score from Baseline to 1 Month
Time frame: baseline, 1 month
The depression score will be measured by the NIH Promis Emotional Distress-Depression Short Form 6a. The survey has 6 questions prompts evaluating depression levels over the past week. The survey ranges from a lowest score of 0 indicating minimal to no depression and a highest score of 30 indicating severe depression. These surveys will evaluate change in depression from baseline to 1 month.
Change in Depression Score from Baseline to 3 Months
Time frame: Baseline, 3 months
The depression score will be measured by the NIH Promis Emotional Distress-Depression Short Form 6a. The survey has 6 questions prompts evaluating depression levels over the past week. The survey ranges from a lowest score of 0 indicating minimal to no depression and a highest score of 30 indicating severe depression. These surveys will evaluate change in depression from baseline to 3 months.
Change in Burnout Score from Baseline to 1 Month
Time frame: baseline, 1 month
Changes in feelings of burnout will be measured by the Maslach Burnout Inventory for Medical Personnel and will be assessed between baseline and 1 month. This survey has 22 question prompts related to how the employee feels from work related stress over the course of year. Respondents rate items on a frequency scale from 0 (Never) to 6 (Every day). The scores for the following three categories are added up independently: * Emotional Exhaustion (EE): 9 items summed to a range of 0 to 54. Higher scores mean greater emotional depletion while lower score indicate less emotional exhaustion * Depersonalization / Cynicism (DP): 5 items summed to a range of 0 to 30. Higher scores mean greater detachment and cynicism while lower scores indicate less detachment or cynicism * Personal Accomplishment (PA): 8 items summed to a range of 0 to 48. Lower scores indicate reduced professional efficacy and a higher risk of burnout while higher scores indicate less burnout risk and more accomplishment.
Change in Burnout Score from Baseline to 3 Months
Time frame: Baseline, 3 months
Changes in feelings of burnout will be measured by the Maslach Burnout Inventory for Medical Personnel and will be assessed between baseline and 1 month. This survey has 22 question prompts related to how the employee feels from work related stress over the course of year. Respondents rate items on a frequency scale from 0 (Never) to 6 (Every day). The scores for the following three categories are added up independently: * Emotional Exhaustion (EE): 9 items summed to a range of 0 to 54. Higher scores mean greater emotional depletion while lower score indicate less emotional exhaustion * Depersonalization / Cynicism (DP): 5 items summed to a range of 0 to 30. Higher scores mean greater detachment and cynicism while lower scores indicate less detachment or cynicism * Personal Accomplishment (PA): 8 items summed to a range of 0 to 48. Lower scores indicate reduced professional efficacy and a higher risk of burnout while higher scores indicate less burnout risk and greater accomplishment
Change in Sleep Disturbance from Baseline to 1 Month
Time frame: baseline, 1 month
Change in sleep disturbance between 1 month and baseline will be evaluated with the Insomnia Severity Index which has 7 question prompts. The survey ranges from a low score of 0 indicating no sleep disturbance to a maximum score of 28 indicating severe clinical insomnia.
Change in Sleep Disturbance from Baseline to 3 Month
Time frame: Baseline, 3 Months
Change in sleep disturbance between 3 month and baseline will be evaluated with the Insomnia Severity Index which has 7 question prompts. The survey ranges from a low score of 0 indicating no sleep disturbance to a maximum score of 28 indicating severe clinical insomnia.
4 secondary outcomes
Change Mental Well-Being from Baseline to 1 month
Time frame: baseline, 1 month
Change in Mental Well Being from Baseline to 3 Months
Time frame: baseline, 3 month
Change in Resilience Score from Baseline to 1 Month
Time frame: baseline, 1 month
Change in Resilience Score from Baseline to 3 Months
Time frame: Baseline, 3 Months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Oct 2026.
- Individual participant dataSharing planned: No
Related trials for Anxiety
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
Recruiting
Unified Protocol in Penitentiary Facilities
Depression Disorders, Anxiety
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
Recruiting
Effect of a Brief Daily Digital Meditation on Well-Being in US Young Adults (BEGIN II)
Mental Health and General Well-being
Not yet recruitingObservational study
Functional Impact of Psychological Symptoms in Patients With Superior Semicircular Canal Dehiscence Syndrome (SSCD): a National Cross-sectional Study
Superior Semicircular Canal Dehiscence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Joseph Osborne, MD, PhD principal investigator
Weill Cornell Medicine Department of Nuclear Medicine
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Transcendental Meditation in people with Anxiety and Depression - Major Depressive Disorder, run by Weill Medical College of Cornell University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 9 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Joseph Osborne, MD, PhD ((212) 746-6797, jro7001@med.cornell.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Adherence to home practice of TM (1 month from baseline) (time frame: 1 month). The study lists 11 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2026.